EDAP, based in Lyon, France, now has FDA clearance to bring to the U.S. its Focal One high intensity focused ultrasound system. It’s used to ablate prostate tissue in a non-invasive way, relying on sound waves to resonate tissue apart at the cellular level.
A urologist, using the system, combines imagery from previously obtained MRI scans an (Read more...)